According to Alibaba Health Information Technology's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 287.988. At the end of 2022 the company had a P/E ratio of 351.
Year | P/E ratio | Change |
---|---|---|
2022 | 351 | -148.8% |
2021 | -720 | -196.89% |
2020 | 743 | -94.06% |
2019 | > 1000 | -1755.69% |
2018 | -756 | 437.96% |
2017 | -141 | -13.86% |
2016 | -163 | -16.82% |
2015 | -196 | -99.9% |
2014 | < -1000 | 515084.24% |
2013 | -36.3 | -122.42% |
2012 | 162 | -426.1% |
2011 | -49.7 | -30.96% |
2010 | -71.9 | 2077.07% |
2009 | -3.30 | -86.56% |
2008 | -24.6 | -49.62% |
2007 | -48.8 | -112% |
2006 | 406 | -106.19% |
2005 | < -1000 | 330.27% |
2004 | < -1000 |
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.